Periodic Reporting for period 4 - VISION DMD (VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy)

The objective of the VISION-DMD project was to advance and accelerate the clinical development of the orphan drug vamorolone (VBP15) for the treatment of Duchenne Muscular Dystrophy (DMD) through Phase 2a and 2b clinical trials. DMD is a progressive and severe, rare genetic...